{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:59:39Z","timestamp":1790211579015,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00125-025-06543-y","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T03:39:51Z","timestamp":1758685191000},"page":"2854-2866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6570-9948","authenticated-orcid":false,"given":"Frederico G. S.","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchenchu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melena D.","family":"Bellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Cusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogish C.","family":"Kudva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter G.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeb I.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"Considine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark O.","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil A.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"3","key":"6543_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","volume":"1","author":"PA Hart","year":"2016","unstructured":"Hart PA, Bellin MD, Andersen DK et al (2016) Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1(3):226\u2013237. https:\/\/doi.org\/10.1016\/S2468-1253(16)30106-6","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"6543_CR2","first-page":"101","volume":"159","author":"J Permert","year":"1993","unstructured":"Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J (1993) Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159(2):101\u2013107","journal-title":"Eur J Surg"},{"issue":"7","key":"6543_CR3","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A (2019) Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology 156(7):2024\u20132040. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.259","journal-title":"Gastroenterology"},{"issue":"7","key":"6543_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrgastro.2013.49","volume":"10","author":"RP Sah","year":"2013","unstructured":"Sah RP, Nagpal SJ, Mukhopadhyay D, Chari ST (2013) New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol 10(7):423\u2013433. https:\/\/doi.org\/10.1038\/nrgastro.2013.49","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"6543_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"R Pannala","year":"2008","unstructured":"Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST (2008) Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134(4):981\u2013987. https:\/\/doi.org\/10.1053\/j.gastro.2008.01.039","journal-title":"Gastroenterology"},{"issue":"7","key":"6543_CR6","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2337\/dci20-0022","volume":"43","author":"WK Chung","year":"2020","unstructured":"Chung WK, Erion K, Florez JC et al (2020) Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43(7):1617\u20131635. https:\/\/doi.org\/10.2337\/dci20-0022","journal-title":"Diabetes Care"},{"issue":"7","key":"6543_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S2468-1253(19)30416-9","volume":"5","author":"SP Pereira","year":"2020","unstructured":"Pereira SP, Oldfield L, Ney A et al (2020) Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol 5(7):698\u2013710. https:\/\/doi.org\/10.1016\/S2468-1253(19)30416-9","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"6543_CR8","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1210\/clinem\/dgac670","volume":"108","author":"PA Hart","year":"2023","unstructured":"Hart PA, Kudva YC, Yadav D et al (2023) A reduced pancreatic polypeptide response is associated with new-onset pancreatogenic diabetes versus type 2 diabetes. J Clin Endocrinol Metab 108(5):e120\u2013e128. https:\/\/doi.org\/10.1210\/clinem\/dgac670","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"6543_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/jnci\/djt123","volume":"105","author":"BM Wolpin","year":"2013","unstructured":"Wolpin BM, Bao Y, Qian ZR et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function, and risk of pancreatic cancer. J Natl Cancer Inst 105(14):1027\u20131035. https:\/\/doi.org\/10.1093\/jnci\/djt123","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"6543_CR10","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.14309\/ajg.0000000000000956","volume":"115","author":"NH Kim","year":"2020","unstructured":"Kim NH, Chang Y, Lee SR, Ryu S, Kim HJ (2020) Glycemic status, insulin resistance, and risk of pancreatic cancer mortality in individuals with and without diabetes. Am J Gastroenterol 115(11):1840\u20131848. https:\/\/doi.org\/10.14309\/ajg.0000000000000956","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"6543_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.14309\/ajg.0000000000001104","volume":"116","author":"FGS Toledo","year":"2021","unstructured":"Toledo FGS, Chari S, Yadav D (2021) Understanding the contribution of insulin resistance to the risk of pancreatic cancer. Am J Gastroenterol 116(4):669\u2013670. https:\/\/doi.org\/10.14309\/ajg.0000000000001104","journal-title":"Am J Gastroenterol"},{"key":"6543_CR12","doi-asserted-by":"publisher","unstructured":"Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J (1993) Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 165(1):61\u201366; discussion 66\u201367. https:\/\/doi.org\/10.1016\/s0002-9610(05)80405-2","DOI":"10.1016\/s0002-9610(05)80405-2"},{"issue":"8","key":"6543_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/bjs.1800800841","volume":"80","author":"J Permert","year":"1993","unstructured":"Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J (1993) Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80(8):1047\u20131050. https:\/\/doi.org\/10.1002\/bjs.1800800841","journal-title":"Br J Surg"},{"issue":"3","key":"6543_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00006676-199405000-00008","volume":"9","author":"D Basso","year":"1994","unstructured":"Basso D, Plebani M, Fogar P et al (1994) Beta-cell function in pancreatic adenocarcinoma. Pancreas 9(3):332\u2013335. https:\/\/doi.org\/10.1097\/00006676-199405000-00008","journal-title":"Pancreas"},{"issue":"2","key":"6543_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1464-5491.1985.tb00612.x","volume":"2","author":"JN Fox","year":"1985","unstructured":"Fox JN, Frier BM, Armitage M, Ashby JP (1985) Abnormal insulin secretion in carcinoma of the pancreas: response to glucagon stimulation. Diabet Med 2(2):113\u2013116. https:\/\/doi.org\/10.1111\/j.1464-5491.1985.tb00612.x","journal-title":"Diabet Med"},{"issue":"10","key":"6543_CR16","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/MPA.0000000000001167","volume":"47","author":"J Serrano","year":"2018","unstructured":"Serrano J, Andersen DK, Forsmark CE et al (2018) Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: from concept to reality. Pancreas 47(10):1208\u20131212. https:\/\/doi.org\/10.1097\/MPA.0000000000001167","journal-title":"Pancreas"},{"issue":"5","key":"6543_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPA.0000000000001037","volume":"47","author":"JL Abbruzzese","year":"2018","unstructured":"Abbruzzese JL, Andersen DK, Borrebaeck CAK et al (2018) The interface of pancreatic cancer with diabetes, obesity, and inflammation: research gaps and opportunities: summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop. Pancreas 47(5):516\u2013525. https:\/\/doi.org\/10.1097\/MPA.0000000000001037","journal-title":"Pancreas"},{"issue":"10","key":"6543_CR18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/MPA.0000000000001168","volume":"47","author":"PA Hart","year":"2018","unstructured":"Hart PA, Andersen DK, Mather KJ et al (2018) Evaluation of a mixed meal test for diagnosis and characterization of pancreatogenic diabetes secondary to pancreatic cancer and chronic pancreatitis: rationale and methodology for the DETECT study from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas 47(10):1239\u20131243. https:\/\/doi.org\/10.1097\/MPA.0000000000001168","journal-title":"Pancreas"},{"issue":"10","key":"6543_CR19","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/MPA.0000000000001169","volume":"47","author":"A Maitra","year":"2018","unstructured":"Maitra A, Sharma A, Brand RE et al (2018) A prospective study to establish a new-onset diabetes cohort: from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas 47(10):1244\u20131248. https:\/\/doi.org\/10.1097\/MPA.0000000000001169","journal-title":"Pancreas"},{"issue":"10","key":"6543_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/MPA.0000000000001170","volume":"47","author":"D Yadav","year":"2018","unstructured":"Yadav D, Park WG, Fogel EL et al (2018) Prospective evaluation of chronic pancreatitis for epidemiologic and translational studies: rationale and study design for PROCEED from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas 47(10):1229\u20131238. https:\/\/doi.org\/10.1097\/MPA.0000000000001170","journal-title":"Pancreas"},{"issue":"10","key":"6543_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/MPA.0000000000001171","volume":"47","author":"WE Fisher","year":"2018","unstructured":"Fisher WE, Cruz-Monserrate Z, McElhany AL et al (2018) Standard operating procedures for biospecimen collection, processing, and storage: from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas 47(10):1213\u20131221. https:\/\/doi.org\/10.1097\/MPA.0000000000001171","journal-title":"Pancreas"},{"issue":"9","key":"6543_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462\u20131470. https:\/\/doi.org\/10.2337\/diacare.22.9.1462","journal-title":"Diabetes Care"},{"issue":"3","key":"6543_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1464-5491.1994.tb00273.x","volume":"11","author":"DI Phillips","year":"1994","unstructured":"Phillips DI, Clark PM, Hales CN, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11(3):286\u2013292. https:\/\/doi.org\/10.1111\/j.1464-5491.1994.tb00273.x","journal-title":"Diabet Med"},{"issue":"1","key":"6543_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1758-5996-5-38","volume":"5","author":"T Chen","year":"2013","unstructured":"Chen T, Xu F, Su JB et al (2013) Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance. Diabetol Metab Syndr 5(1):38. https:\/\/doi.org\/10.1186\/1758-5996-5-38","journal-title":"Diabetol Metab Syndr"},{"issue":"12","key":"6543_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","volume":"21","author":"JC Levy","year":"1998","unstructured":"Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21(12):2191\u20132192. https:\/\/doi.org\/10.2337\/diacare.21.12.2191","journal-title":"Diabetes Care"},{"issue":"2","key":"6543_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13105-015-0458-0","volume":"72","author":"JL Santos","year":"2016","unstructured":"Santos JL, Yevenes I, Cataldo LR et al (2016) Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status. J Physiol Biochem 72(2):121\u2013131. https:\/\/doi.org\/10.1007\/s13105-015-0458-0","journal-title":"J Physiol Biochem"},{"issue":"1","key":"6543_CR27","doi-asserted-by":"publisher","first-page":"e000825","DOI":"10.1136\/bmjdrc-2019-000825","volume":"7","author":"Z Semnani-Azad","year":"2019","unstructured":"Semnani-Azad Z, Johnston LW, Lee C et al (2019) Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort. BMJ Open Diabetes Res Care 7(1):e000825. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000825","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"6543_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","volume":"9","author":"L Li","year":"2013","unstructured":"Li L, Greene T (2013) A weighting analogue to pair matching in propensity score analysis. Int J Biostat 9(2):215\u2013234. https:\/\/doi.org\/10.1515\/ijb-2012-0030","journal-title":"Int J Biostat"},{"issue":"7","key":"6543_CR29","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s00125-017-4275-6","volume":"60","author":"A Hulman","year":"2017","unstructured":"Hulman A, Simmons RK, Brunner EJ et al (2017) Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia 60(7):1252\u20131260. https:\/\/doi.org\/10.1007\/s00125-017-4275-6","journal-title":"Diabetologia"},{"issue":"2","key":"6543_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1006\/bbrc.1999.0521","volume":"257","author":"A Valerio","year":"1999","unstructured":"Valerio A, Basso D, Brigato L et al (1999) Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved. Biochem Biophys Res Commun 257(2):622\u2013628. https:\/\/doi.org\/10.1006\/bbrc.1999.0521","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"6543_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJM199402033300503","volume":"330","author":"J Permert","year":"1994","unstructured":"Permert J, Larsson J, Westermark GT et al (1994) Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 330(5):313\u2013318. https:\/\/doi.org\/10.1056\/NEJM199402033300503","journal-title":"N Engl J Med"},{"issue":"3","key":"6543_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1053\/gast.2001.27210","volume":"121","author":"ST Chari","year":"2001","unstructured":"Chari ST, Klee GG, Miller LJ, Raimondo M, DiMagno EP (2001) Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 121(3):640\u2013645. https:\/\/doi.org\/10.1053\/gast.2001.27210","journal-title":"Gastroenterology"},{"issue":"22","key":"6543_CR33","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1001\/jama.294.22.2872","volume":"294","author":"RZ Stolzenberg-Solomon","year":"2005","unstructured":"Stolzenberg-Solomon RZ, Graubard BI, Chari S et al (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872\u20132878. https:\/\/doi.org\/10.1001\/jama.294.22.2872","journal-title":"JAMA"},{"key":"6543_CR34","doi-asserted-by":"publisher","first-page":"109223","DOI":"10.1016\/j.diabres.2022.109223","volume":"185","author":"J Bao","year":"2022","unstructured":"Bao J, Liu D, Sun J et al (2022) Pancreatic cancer-associated diabetes mellitus is characterized by reduced beta-cell secretory capacity, rather than insulin resistance. Diabetes Res Clin Pract 185:109223. https:\/\/doi.org\/10.1016\/j.diabres.2022.109223","journal-title":"Diabetes Res Clin Pract"},{"key":"6543_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev-physiol-031622-043133","volume":"85","author":"SM Najjar","year":"2023","unstructured":"Najjar SM, Caprio S, Gastaldelli A (2023) Insulin clearance in health and disease. Annu Rev Physiol 85:363\u2013381. https:\/\/doi.org\/10.1146\/annurev-physiol-031622-043133","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"6543_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pan.2016.12.004","volume":"17","author":"J Skrha","year":"2017","unstructured":"Skrha J, Busek P, Uhrova J et al (2017) Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss. Pancreatology 17(1):89\u201394. https:\/\/doi.org\/10.1016\/j.pan.2016.12.004","journal-title":"Pancreatology"},{"issue":"5","key":"6543_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.pan.2016.06.001","volume":"16","author":"P Busek","year":"2016","unstructured":"Busek P, Vanickova Z, Hrabal P et al (2016) Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Pancreatology 16(5):829\u2013838. https:\/\/doi.org\/10.1016\/j.pan.2016.06.001","journal-title":"Pancreatology"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06543-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:01:46Z","timestamp":1790208106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06543-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6543"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06543-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors would like to acknowledge J.A. Rinaudo and A. Unalp-Arida (NIH) for their ongoing support throughout the duration of the DETECT study, as well as L. Li (University of Texas MD Anderson Cancer Center), the developer of the MW PS analysis method, who provided advice.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Samples and data will be available to the scientific community according to the NIH data-sharing policy and the NIDDK policy for data sharing in multicentre clinical studies after the completion of the DETECT study.","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Research reported in this publication was supported by the National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the following award numbers: U01DK108306 (University of Pittsburgh), U01DK108288 (Mayo Clinic), U01DK108320 (University of Florida), U01DK108323 (Indiana University), U01DK108326 (Baylor College of Medicine), U01DK108327 (Ohio State University), U01DK108328 (University of Texas MD Anderson Cancer Center), U01DK108300 (Stanford University), U01DK108314, P30DK063491 (Cedars-Sinai Medical Center), U01DK126300 (University of Minnesota) and P30DK097512 (Indiana University). MOG was supported by the Eris M. Field Chair in Diabetes Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"FGST discloses research support by Domp\u00e9 and has served on advisory boards for Sanofi and Novo Nordisk. MDB discloses research support from Viacyte and Dexcom, is a member of the data safety monitoring boards for Vertex and Insulet and is an advisory board member for Ariel Precision Medicine. RB discloses research support from Immunovia and Freenome. YCK discloses research support from Dexcom; is an advisory board honoraria for Novo Nordisk Walter Park; is an advisory committee\/board member for AbbVie, Ariel Medicine, Pfizer, Ionis, Horizon Therapeutics and Nestle; and is a consultant for Acumen, Olympus, Arctx Medical and Capsovision. DY discloses research support from Abbvie Pharmaceuticals and is an advisory board member for Pfizer. RVC receives research support from Adipo Therapeutics. MOG has served on advisory boards for Nestle Health Science and Organon. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"FGST designed the concept and analysis plan and wrote the first draft of the manuscript. FGST, YL, MOG and PAH analysed the data and wrote the manuscript. YL and FW performed the statistical analyses. FGST, YL, FW, MDB, RB, KC, WF, YCK, WGP, ZIS, DY, RVC, SCG, DKA, JS, MOG and PAH contributed to the study design, data collection and recruitment. All authors provided critical input on the manuscript and approved the final version. FGST and YL are the guarantors of this work and take responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}